Chemodex

Saroglitazar magnesium

Product Code:
 
CDX-S0378
Product Group:
 
Other Biochemicals
Supplier:
 
Chemodex
Regulatory Status:
 
RUO
Shipping:
 
Ambient
Storage:
 
Short term: +4°C. Long term: -20°C
1 / 1
Chemical Structure
❮❯

Chemical Structure

No additional charges, what you see is what you pay! *

CodeSizePrice
CDX-S0378-M0055 mg£139.00
Quantity:
CDX-S0378-M02525 mg£522.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges to UK mainland customers, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Switzerland.
Typical lead time: 7-10 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Appearance:
White to beige powder.
CAS:
1639792-20-3
Description:
Saroglitazar is a potent and selective PPARalpha/gamma (peroxisome proliferator-activated receptor) agonist that exhibits lipid-lowering, antidiabetic and insulin-sensitizing effects. It also shows neuroprotective properties.
EClass:
32160000
Form:
solid
Handling Advice:
Protect from light and moisture.
InChi:
InChI=1S/2C25H29NO4S.Mg/c2*1-4-29-24(25(27)28)17-19-6-10-21(11-7-19)30-16-15-26-18(2)5-14-23(26)20-8-12-22(31-3)13-9-20;/h2*5-14,24H,4,15-17H2,1-3H3,(H,27,28);/q;;+2/p-2/t2*24-;/m00./s1
InChiKey:
UJYFZCVPOSZDMK-YPPDDXJESA-L
MDL:
MFCD29075338
Molecular Formula:
C50H56MgN2O8S2
Molecular Weight:
901.44
Package Type:
Vial
Purity:
>98% (HPLC)
SMILES:
CC1=CC=C(C2=CC=C(SC)C=C2)N1CCOC(C=C3)=CC=C3CC4[O]([Mg+2]([O-]C4=O)([O-]C5=O)[O](C5CC6=CC=C(OCCN7C(C8=CC=C(SC)C=C8)=CC=C7C)C=C6)CC)CC
Solubility Chemicals:
Soluble in DMSO (2mg/ml).
Source / Host:
Synthetic
Transportation:
Non-hazardous
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at -20°C.

Documents

References

(1) R.H. Jani, et al.; Clin. Drug Investig. 33, 809 (2013) | (2) M.R. Jain, et al.; Pharmacol. Res. Perspect. 3, e00136 (2015) | (3) D. Kumar, et al.; Eur. J. Pharmacol. 822, 32 (2018) | (4) M.R. Jain, et al.; Liver Int. 38, 1084 (2018) | (5) R.N. Dharavath, et al.; Life Sci. 271, 119191 (2021) | (6) S. Francque; Hepatology 74, 1730 (2021) | (7) G. Sandeep Ganesh, et al.; ACS Chem. Neurosci. 14, 3444 (2023) | (8) D. Ezhilarasan; Metabolism 155, 155912 (2024) (Review)